Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Embecta Corp

Healthcare US EMBC

3.34USD
-0.04(1.18%)

Last update at 2026-06-08T20:00:00Z

Day Range

3.313.40
LowHigh

52 Week Range

8.4715.13
LowHigh

Fundamentals

  • Previous Close 3.38
  • Market Cap540.68M
  • Volume1584239
  • P/E Ratio3.87
  • Dividend Yield6.25%
  • EBITDA366.70M
  • Revenue TTM1079.70M
  • Revenue Per Share TTM18.45
  • Gross Profit TTM 681.90M
  • Diluted EPS TTM2.36

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Income before tax 136.30M 44.20M 105.70M 256.60M 495.00M
Minority interest - - - - -
Net income 95.40M 78.30M 70.40M 223.60M 415.00M
Selling general administrative 318.00M 356.10M 341.30M 294.80M 240.00M
Selling and marketing expenses 16.20M 9.00M - - 240.00M
Gross profit 679.50M 728.90M 749.90M 774.90M 800.00M
Reconciled depreciation 40.70M 36.20M 32.60M 31.70M 38.00M
Ebit 243.60M 156.50M 215.20M 309.60M 492.00M
Ebitda 294.70M 199.00M 247.80M 393.40M 530.00M
Depreciation and amortization 51.10M 42.50M 32.60M 83.80M 38.00M
Non operating income net other - - - -6.80000M -
Operating income 329.30M 174.20M 221.50M 309.60M 492.00M
Other operating expenses 751.10M 948.90M 896.80M 761.00M 673.00M
Interest expense 107.30M 112.30M 107.00M 46.20M 3.00M
Tax provision 40.90M -34.10000M 35.30M 33.00M 80.00M
Interest income - - - - -
Net interest income -107.30000M -112.30000M -107.00000M -46.20000M -
Extraordinary items - - - - -
Non recurring - - - 58.90M -
Other items - - - - -
Income tax expense 40.90M -34.10000M 35.30M 33.00M 80.00M
Total revenue 1080.40M 1123.10M 1120.80M 1129.50M 1165.00M
Total operating expenses 350.20M 554.70M 525.90M 406.40M 308.00M
Cost of revenue 400.90M 394.20M 370.90M 354.60M 365.00M
Total other income expense net -193.00000M -130.00000M -11.30000M -53.00000M 3.00M
Discontinued operations - - - - -
Net income from continuing ops 95.40M 78.30M 70.40M 223.60M 415.00M
Net income applicable to common shares - - - 223.60M 415.00M
Preferred stock and other adjustments - - - - -
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Total assets 1090.90M 1285.30M 1214.40M 1086.40M 788.00M
Intangible assets 7.00M 8.10M - 8.90M 18.00M
Earning assets - - - - -
Other current assets 78.40M 74.00M 111.40M 306.00M 23.00M
Total liab 1742.10M 2023.60M 2036.10M 1977.80M 194.00M
Total stockholder equity -650.60000M -738.30000M -821.70000M -891.40000M 594.00M
Deferred long term liab - - - 46.10M -
Other current liab 174.40M 243.40M 286.90M 246.50M 110.00M
Common stock 0.60M 0.60M 0.60M 0.60M 865.00M
Capital stock 0.00000M 0.60M 0.60M 0.60M 865.00M
Retained earnings -445.60000M -498.60000M -541.10000M -577.10000M -
Other liab - - - 41.80M 27.00M
Good will 15.40M 15.60M - 15.70M 16.00M
Other assets - - - 89.20M 7.00M
Cash 225.50M 267.50M 326.50M 330.90M -
Cash and equivalents - - - - -
Total current liabilities 261.50M 374.00M 353.50M 301.00M 164.00M
Current deferred revenue - - - - -
Net debt 1204.80M 1340.90M 1312.00M 1312.90M -
Short term debt 12.90M 12.90M 13.10M 13.10M -
Short long term debt 9.50M 9.50M 9.50M 9.50M -
Short long term debt total 1430.30M 1608.40M 1638.50M 1643.80M -
Other stockholder equity 80.00M 52.50M 27.90M 10.00M -271.00000M
Property plant equipment - - - 307.90M 455.00M
Total current assets 631.40M 761.00M 749.10M 664.70M 292.00M
Long term investments - - - - -
Net tangible assets - - - -883.40000M 560.00M
Short term investments - - - - -
Net receivables 148.90M 248.00M 159.10M 133.10M 151.00M
Long term debt 1388.70M 1565.30M 1593.90M 1598.10M -
Inventory 178.60M 171.50M 152.10M 122.80M 118.00M
Accounts payable 74.20M 91.00M 53.50M 41.40M 54.00M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -285.60000M -292.80000M -309.10000M -324.90000M -271.00000M
Additional paid in capital - - - - -
Common stock total equity - - - 0.60M -
Preferred stock total equity - - - - -
Retained earnings total equity - - - -577.10000M -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 368.40M 210.20M 140.40M 95.50M 11.00M
Deferred long term asset charges - - - - -
Non current assets total 459.50M 524.30M 465.30M 421.70M 496.00M
Capital lease obligations 32.10M 33.60M 35.10M 36.20M -
Long term debt total - - - 1598.10M -
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Type yearly yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30 2021-09-30
Investments -9.30000M -15.80000M -26.50000M -24.00000M -39.00000M
Change to liabilities - - - 83.60M 30.00M
Total cashflows from investing activities -9.30000M -15.80000M - -24.00000M -39.00000M
Net borrowings -186.00000M -35.90000M - 1411.90M 1443.40M
Total cash from financing activities -226.70000M -73.40000M -48.70000M -48.00000M -417.00000M
Change to operating activities - - - -90.50000M -12.00000M
Net income 95.40M 78.30M 70.40M 223.60M 415.00M
Change in cash -45.60000M -52.30000M -4.40000M 330.90M -417.00000M
Begin period cash flow 274.20M 326.50M 330.90M 0.00000M 0.00000M
End period cash flow 228.60M 274.20M 326.50M 330.90M 0.00000M
Total cash from operating activities 191.70M 35.70M 67.70M 412.20M 456.00M
Issuance of capital stock - - - - -
Depreciation 40.70M 36.20M 32.60M 31.70M 38.00M
Other cashflows from investing activities - - - -0.40000M -
Dividends paid 35.00M 34.50M 34.40M 8.60M 8.60M
Change to inventory -6.10000M -16.50000M -28.80000M -23.40000M -18.00000M
Change to account receivables 44.20M -174.70000M 7.00M 122.70M -32.00000M
Sale purchase of stock -5.70000M -3.00000M - - -
Other cashflows from financing activities -5.70000M -3.00000M -3.60000M -32.80000M -417.00000M
Change to netincome - - - 51.10M 35.00M
Capital expenditures 9.30M 15.80M 26.50M 24.00M 39.00M
Change receivables - - - 122.70M -
Cash flows other operating - - - -80.30000M -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - 340.20M -
Change in working capital -23.70000M -47.70000M -80.00000M 92.40M -32.00000M
Stock based compensation 31.60M 26.30M 21.50M 18.70M 13.00M
Other non cash items 30.10M 13.20M 8.90M 72.30M 24.00M
Free cash flow 182.40M 19.90M 41.20M 388.20M 417.00M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
EMBC
Embecta Corp		 -0.04 1.18% 3.34 3.87 - 0.50 2.61 1.63 5.16
ISRG
Intuitive Surgical Inc		 8.01 1.91% 426.62 73.05 61.73 19.15 10.25 18.41 59.92
ESLOF
EssilorLuxottica Société anonyme		 -2.85 1.41% 199.02 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 0.24 0.24% 99.55 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 0.69 0.46% 149.63 25.56 12.48 2.59 1.76 2.89 12.55

Reports Covered

Stock Research & News

View All

Profile

Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Embecta Corp

300 Kimball Drive, Parsippany, NJ, United States, 07054

Key Executives

Name Title Year Born
Mr. Devdatt Kurdikar Pres, CEO & Director 1969
Mr. Jacob P. Elguicze Sr. VP & CFO 1973
Mr. Jeffrey Z. Mann Sr. VP, Gen. Counsel, Head of Corp. Devel. & Corp. Sec. 1973
Mr. Ajay Kumar Sr. VP & Chief HR Officer 1971
Mr. Shaun Curtis Sr. VP of Global Manufacturing & Supply Chain 1970
Mr. Brian R. Capone VP, Chief Accounting Officer & Corp. Controller 1975
Ms. Colleen Riley Sr. VP & Chief Technology Officer 1965
Ms. Ginny Blocki Sr. VP of Global Marketing & Product Management NA
Mr. Tom Blount Sr. VP & Pres of North America 1974
Mr. Slobodan Radumilo Sr. VP & Pres of International 1971

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.